Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,995,225,212
+$2,851,610,828 QoQ
Shares Held
8,043,052
+214.1% QoQ
Ownership
3.17%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#6
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,026 across 296 Biotechnology names. VRTX ranks #1 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,995,225,212 | 8,043,052 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,143,614,384 | 2,561,057 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $975,935,371 | 2,152,672 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $821,189,566 | 2,096,797 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $883,297,273 | 1,984,046 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $894,803,178 | 1,845,640 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $764,508,626 | 1,898,457 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $903,931,340 | 1,943,604 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $844,981,218 | 1,802,742 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $874,118,674 | 2,091,143 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $912,290,908 | 2,242,107 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $701,315,066 | 2,016,780 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $685,988,358 | 1,949,329 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $586,461,206 | 1,861,368 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $469,238,321 | 1,624,899 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $382,100,717 | 1,319,682 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $316,392,113 | 1,122,794 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $315,866,858 | 1,210,357 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $246,425,893 | 1,122,158 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $220,296,877 | 1,214,493 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $235,117,309 | 1,166,083 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $208,140,085 | 968,589 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $259,482,643 | 1,097,921 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $307,758,732 | 1,130,967 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $325,062,713 | 1,119,709 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $309,749,265 | 1,301,741 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||